Dr. Richard Lee on why it’s “a wonderful time” for BPH treatment

“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.

In this interview, Richard K. Lee, MD, MBA, discusses the recent paper European Urology Focus paper, New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review, for which he served senior author. Lee is an Associate Professor of Urology and Healthcare Policy & Research at Weill Cornell Medicine Department of Urology in New York City.

Related Content:

UTvBenign Prostatic Hyperplasia
Dr. Kang discusses what a recent study of prostate MRI means for clinicians and patients
Prostatic urethral lift gaining on TURP as treatment choice for benign prostatic enlargement/LUTS
Pembrolizumab demonstrates efficacy as part of trimodal treatment in bladder cancer